2022
DOI: 10.1007/7355_2022_150
|View full text |Cite
|
Sign up to set email alerts
|

From DEL Selections to Validated Hits to Clinical Leads

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 84 publications
0
1
0
Order By: Relevance
“…Because it is inexpensive, is efficient, and enables the use of a plethora of chemical building blocks and reaction types (15), DEL technology has been routinely implemented for small-molecule drug discovery in both industry and academia (24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37). It is increasingly filling the pharmaceutical companies' pipelines (38) and swiftly providing valuable chemical probes for basic cellular and molecular biology and proteomics research (16,39); in contrast to biomacromolecules, small molecules exhibit distinct pharmacokinetic advantages and are typically cell permeable (40).…”
mentioning
confidence: 99%
“…Because it is inexpensive, is efficient, and enables the use of a plethora of chemical building blocks and reaction types (15), DEL technology has been routinely implemented for small-molecule drug discovery in both industry and academia (24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35)(36)(37). It is increasingly filling the pharmaceutical companies' pipelines (38) and swiftly providing valuable chemical probes for basic cellular and molecular biology and proteomics research (16,39); in contrast to biomacromolecules, small molecules exhibit distinct pharmacokinetic advantages and are typically cell permeable (40).…”
mentioning
confidence: 99%